1. Home
  2. ARVN vs SLDP Comparison

ARVN vs SLDP Comparison

Compare ARVN & SLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$10.92

Market Cap

781.0M

Sector

Health Care

ML Signal

HOLD

Logo Solid Power Inc.

SLDP

Solid Power Inc.

HOLD

Current Price

$3.30

Market Cap

662.3M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
SLDP
Founded
2015
2011
Country
United States
United States
Employees
N/A
230
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
781.0M
662.3M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ARVN
SLDP
Price
$10.92
$3.30
Analyst Decision
Buy
Strong Buy
Analyst Count
19
2
Target Price
$15.05
$7.00
AVG Volume (30 Days)
781.8K
3.9M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
N/A
EPS
N/A
N/A
Revenue
$262,600,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$48.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.90
$1.06
52 Week High
$14.22
$8.86

Technical Indicators

Market Signals
Indicator
ARVN
SLDP
Relative Strength Index (RSI) 44.75 56.44
Support Level $9.02 $2.88
Resistance Level $12.43 $3.48
Average True Range (ATR) 0.63 0.18
MACD 0.07 0.07
Stochastic Oscillator 44.71 51.94

Price Performance

Historical Comparison
ARVN
SLDP

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About SLDP Solid Power Inc.

Solid Power Inc develops solid-state battery technology and manufacturing processes. Its sulfide-based solid electrolyte material replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells and enables improvement in energy density, battery life and safety performance. The company produces electrolytes on two pilot manufacturing lines using a batch manufacturing process for customer sampling and internal cell development, and manufactures solid-state cells on pre-pilot and pilot cell manufacturing lines. Its cell manufacturing processes are developed around industry-standard lithium-ion battery manufacturing processes and equipment, and it manufactures all cell designs, including cathodes and anodes, using materials sourced from external suppliers.

Share on Social Networks: